These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A Meta-analysis for the Diagnostic Performance of Transient Elastography for Clinically Significant Portal Hypertension. You MW, Kim KW, Pyo J, Huh J, Kim HJ, Lee SJ, Park SH. Ultrasound Med Biol; 2017 Jan; 43(1):59-68. PubMed ID: 27751595 [Abstract] [Full Text] [Related]
12. Non-invasive tests for clinically significant portal hypertension after HCV cure. Semmler G, Lens S, Meyer EL, Baiges A, Alvardo-Tapias E, Llop E, Tellez L, Schwabl P, Mauro E, Escudé L, Díez C, Ibañez-Samaniego L, Puente Á, Fortea JI, Abadía M, Zanetto A, Conthe A, Hernandez-Évole H, Luzko Scheid IS, Jia J, Yoshiji H, Francque SM, Tsochatzis EA, Russo FP, Crespo G, Forns X, Bañares R, Villanueva C, Hernández-Gea V, Reiberger T, Bosch J, García Pagán JC, Mandorfer M, A study by the Baveno Cooperation: an EASL consortium. J Hepatol; 2022 Dec; 77(6):1573-1585. PubMed ID: 36063968 [Abstract] [Full Text] [Related]
13. Validation of the New Diagnostic Criteria for Clinically Significant Portal Hypertension by Platelets and Elastography. Podrug K, Trkulja V, Zelenika M, Bokun T, Madir A, Kanizaj TF, O'Beirne J, Grgurevic I. Dig Dis Sci; 2022 Jul; 67(7):3327-3332. PubMed ID: 34739624 [Abstract] [Full Text] [Related]
14. Similar performance of liver stiffness measurement and liver surface nodularity for the detection of portal hypertension in patients with hepatocellular carcinoma. Souhami A, Sartoris R, Rautou PE, Cauchy F, Bouattour M, Durand F, Giannelli V, Gigante E, Castera L, Valla D, Soubrane O, Vilgrain V, Ronot M. JHEP Rep; 2020 Oct; 2(5):100147. PubMed ID: 32885156 [Abstract] [Full Text] [Related]
15. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. Semmler G, Stift J, Scheiner B, Wöran K, Schwabl P, Paternostro R, Bucsics T, Stättermayer AF, Pinter M, Ferlitsch A, Trauner M, Reiberger T, Mandorfer M. Dig Dis Sci; 2019 Dec; 64(12):3642-3651. PubMed ID: 31209721 [Abstract] [Full Text] [Related]
16. MR elastography outperforms shear wave elastography for the diagnosis of clinically significant portal hypertension. Kennedy P, Stocker D, Carbonell G, Said D, Bane O, Hectors S, Abboud G, Cuevas J, Bolster BD, Friedman SL, Lewis S, Schiano T, Bhattacharya D, Fischman A, Thung S, Taouli B. Eur Radiol; 2022 Dec; 32(12):8339-8349. PubMed ID: 35727321 [Abstract] [Full Text] [Related]
17. High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease. Odriozola A, Puente Á, Cuadrado A, Iruzubieta P, Arias-Loste MT, Redondo C, Rivas C, Fábrega E, Crespo J, Fortea JI. Liver Int; 2023 Jul; 43(7):1446-1457. PubMed ID: 36912787 [Abstract] [Full Text] [Related]
18. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience. Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, Trauner M, Peck-Radosavljevic M. Wien Klin Wochenschr; 2012 Jun; 124(11-12):395-402. PubMed ID: 22699260 [Abstract] [Full Text] [Related]
19. Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension. Hai Y, Chong W, Eisenbrey JR, Forsberg F. Dig Dis Sci; 2022 Jul; 67(7):3313-3326. PubMed ID: 34275089 [Abstract] [Full Text] [Related]
20. Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis. Song J, Ma Z, Huang J, Liu S, Luo Y, Lu Q, Schwabl P, Zykus R, Kumar A, Kitson M. Eur Radiol; 2018 Dec; 28(12):5221-5230. PubMed ID: 29858640 [Abstract] [Full Text] [Related] Page: [Next] [New Search]